CLOVIS ONCOLOGY INC (CLVS)

US1894641000 - Common Stock

0.0812  0 (-5.58%)

After market: 0.078 0 (-3.94%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
133.02M148.76M164.50M143.00M95.40M
Cost Of Goods
36.97M38.83M41.30M34.70M22.10M
Gross Profit
96.06M109.93M123.20M108.30M73.30M
Operating Expenses
302.74M330.22M425.40M475.60M407.10M
Research and Development
151.28M186.60M257.70M283.10M231.30M
Selling, General, and Administrative Expenses
125.53M128.40M163.90M182.80M175.80M
Operating Income
-206.69M-220.29M-302.10M-367.30M-333.80M
Interest Income/Expense
-43.86M-37.28M-26.20M-20.00M-13.50M
Other Income/Expense
563.00K444.00K-3.00M6.30M7.90M
Non Recurring Items
N/A-7.80M-38.40M-17.70M-28.00M
Income Before Taxes
-252.31M-264.93M-369.80M-398.60M-367.40M
Income Tax
-405.00K-404.00K-500.00K1.80M600.00K
Net Income
-251.91M-264.52M-369.20M-400.40M-368.00M
EBITDA
-198.97M-211.80M-293.90M-359.53M-329.20M
 
Per Share Data
EPS Diluted Total Ops
-1.82-2.29-4.38-7.43-7.06
Non GAAP EPS
-1.81-2.29-4.34-7.49-7.07
 
Statistics
Gross Profit Margin
72.21%73.90%74.89%75.73%76.83%
Profit Margin
-189.37%-177.82%-224.44%-280.00%-385.74%
Operating Profit Margin
-155.38%-148.09%-183.65%-256.85%-349.90%

All data in USD

Charts